Literature DB >> 17973942

The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis.

Stephanie Estcourt1, Bijay Vaidya, Anthony Quinn, Maggie Shepherd.   

Abstract

BACKGROUND: Previous studies using quality of life (QoL) questionnaires have shown poor QoL in patients with thyroid eye disease (TED). However, predetermined questionnaires limit in-depth investigation of psychosocial and emotional effects of TED. A qualitative approach allows detailed exploration of patients' perceptions of wellbeing and can capture their lived experiences.
OBJECTIVE: To explore the experience of living and coping with TED. DESIGN AND PATIENTS: A qualitative study involving individual, tape-recorded, semistructured interviews with 25 participants with TED (20 female subjects, median age 54 years, range 28-90 years). Thematic content analysis identified themes, from which theoretical interpretations were formed.
RESULTS: Three key themes were identified: (1) development of an altered identity as a result of changes in appearance, abilities and roles due to physical consequences of TED. This was described in the context of life before and after TED; (2) creation of coping strategies including denial, social avoidance, adjustment and stoicism; (3) difficult interactions with healthcare practitioners due to uncertainty surrounding the diagnosis, prognosis and treatment choices, resulting in patients' disengagement, anger and frustration.
CONCLUSION: This qualitative study has identified the phenomenon of an altered identity due to direct consequences of TED that impact upon patients' wellbeing, coping strategies and interactions with healthcare professionals.

Entities:  

Mesh:

Year:  2007        PMID: 17973942     DOI: 10.1111/j.1365-2265.2007.03087.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  Orbital decompression for Graves' orbitopathy in England.

Authors:  P Perros; T Chandler; C M Dayan; A J Dickinson; P Foley; J Hickey; C J Macewen; J H Lazarus; J McLaren; G E Rose; J M Uddin; B Vaidya
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

2.  Management of patients in a combined thyroid eye clinic in secondary care.

Authors:  J D Benzimra; A G Quinn; T Kersey; D McGrane; L Goss; B Vaidya
Journal:  Int Ophthalmol       Date:  2013-04-03       Impact factor: 2.031

3.  Measuring quality of life in oculoplastic patients.

Authors:  Edward Ridyard; Clare Inkster
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

4.  Neuroanatomic Variations in Graves' Dysthyroid Ophthalmopathy as Studied With MRI.

Authors:  Rona Z Silkiss; Alex R Wade
Journal:  Trans Am Ophthalmol Soc       Date:  2017-05-24

Review 5.  The eye and thyroid disease.

Authors:  Ajay E Kuriyan; Richard P Phipps; Steven E Feldon
Journal:  Curr Opin Ophthalmol       Date:  2008-11       Impact factor: 3.761

6.  Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy.

Authors:  Xiaomei Liu; Hui Guo; Juan Liu; Bingyin Shi
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

7.  Changes in the Ocular Parameters of Patients with Graves' Disease after Antithyroid Drug Treatment.

Authors:  Je-Sang Lee; Dong-Ju Yeom; Seung-Kwan Nah; Bo-Yeon Kim; Sun-Young Jang
Journal:  Medicina (Kaunas)       Date:  2021-04-25       Impact factor: 2.430

8.  Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.

Authors:  Wen Chen; Qian Wu; Lu Chen; Jiang Zhou; Huan-Huan Chen; Xiao-Quan Xu; Hao Hu; Fei-Yun Wu
Journal:  Front Hum Neurosci       Date:  2021-06-11       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.